Colestipol
- Generic Name
- Colestipol
- Brand Names
- Colestid
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 26658-42-4
- Unique Ingredient Identifier
- K50N755924
- Background
Bile acid sequestrants like colestipol have been in use since the 1970s. And even though such an agent may very well be useful in reducing elevated cholesterol levels and decreasing the risk for atherosclerotic vascular disease due to hypercholesterolemia, colestipol is still generally only employed as an adjunct therapy and the relatively physical nature of...
- Indication
1.Ⅱa型高脂蛋白血症、冠心病危险性大而控制饮食治疗无效者。本品降低血浆总胆固醇和低密度脂蛋白胆固醇浓度，对血清甘油三酯浓度无影响或使之轻度升高，因此，对单纯甘油三酯升高者无效；2.胆管不完全阻塞所致的瘙痒。
- Associated Conditions
- Primary Hypercholesterolemia
- Associated Therapies
- -
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
- Conditions
- Interventions
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Puma Biotechnology, Inc.
- Target Recruit Count
- 563
- Registration Number
- NCT02400476
- Locations
- 🇺🇸
Compassionate Care Research Group Inc., Riverside, California, United States
🇺🇸Emad Ibrahim, M.D., Inc., Redlands, California, United States
🇺🇸The Oncology Institute of Hope and Innovation, Santa Ana, California, United States
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
- Conditions
- Interventions
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- Derrick Scott Robertson
- Target Recruit Count
- 14
- Registration Number
- NCT02263547
- Locations
- 🇺🇸
USF Carol and Frank Morsani Center for Advanced Healthcare, Tampa, Florida, United States
Sorbent Therapy of the Cutaneous Porphyrias
- First Posted Date
- 2011-08-25
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT01422915
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-08-12
- Target Recruit Count
- 30
- Registration Number
- NCT00203476
- Locations
- 🇺🇸
Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa, Alabama, United States
Cholesterol-Lowering Atherosclerosis Study (CLAS)
Familial Atherosclerosis Treatment Study
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 146
- Registration Number
- NCT00000512
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.